ATE286541T1 - Diagnostisches in vitro-verfahren für prostatakrebs sowie hierfür geeignetes testsystem - Google Patents
Diagnostisches in vitro-verfahren für prostatakrebs sowie hierfür geeignetes testsystemInfo
- Publication number
- ATE286541T1 ATE286541T1 AT01938296T AT01938296T ATE286541T1 AT E286541 T1 ATE286541 T1 AT E286541T1 AT 01938296 T AT01938296 T AT 01938296T AT 01938296 T AT01938296 T AT 01938296T AT E286541 T1 ATE286541 T1 AT E286541T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnostic
- prostate cancer
- test system
- suitable test
- kit
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 206010060862 Prostate cancer Diseases 0.000 title abstract 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title abstract 2
- 230000002759 chromosomal effect Effects 0.000 abstract 2
- 230000004075 alteration Effects 0.000 abstract 1
- 238000011394 anticancer treatment Methods 0.000 abstract 1
- 238000001574 biopsy Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0008266A FR2810677B1 (fr) | 2000-06-27 | 2000-06-27 | Procede de diagnostic in vitro du cancer de la prostate et kit de mise en oeuvre |
| PCT/FR2001/001566 WO2002000929A1 (fr) | 2000-06-27 | 2001-05-22 | Procede de diagnostic in vitro du cancer de la prostate et kit de mise en oeuvre |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE286541T1 true ATE286541T1 (de) | 2005-01-15 |
Family
ID=8851762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01938296T ATE286541T1 (de) | 2000-06-27 | 2001-05-22 | Diagnostisches in vitro-verfahren für prostatakrebs sowie hierfür geeignetes testsystem |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1294941B1 (de) |
| AT (1) | ATE286541T1 (de) |
| AU (1) | AU2001263992A1 (de) |
| DE (1) | DE60108245D1 (de) |
| FR (1) | FR2810677B1 (de) |
| WO (1) | WO2002000929A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8076080B2 (en) | 2002-05-21 | 2011-12-13 | Sysmex Corporation | Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers |
| FR2849382A1 (fr) * | 2002-12-26 | 2004-07-02 | Urogene | Utilisation du gene htr2b pour le traitement du cancer de la prostate |
| IL172297A (en) | 2005-10-03 | 2016-03-31 | Compugen Ltd | Soluble vegfr-1 variants for diagnosis of preeclamsia |
| US8273539B2 (en) | 2006-09-25 | 2012-09-25 | Mayo Foundation For Medical Education And Research | Extracellular and membrane-associated prostate cancer markers |
| US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| CA2725978A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| FR2981662A1 (fr) * | 2011-10-20 | 2013-04-26 | Assist Publ Hopitaux De Paris | Methode de quantification de marqueurs renaux par dosage urinaire. |
| EP2791359B1 (de) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Krebsdiagnostik mit nichtcodierenden transkripten |
| ES3015226T3 (en) | 2012-08-16 | 2025-04-30 | Veracyte Sd Inc | Prostate cancer prognosis using biomarkers |
| EP3504348B1 (de) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Verwendung von genomischen signaturen zur vorhersage des ansprechens von patienten mit prostatakrebs auf postoperative strahlentherapie |
| WO2018132916A1 (en) | 2017-01-20 | 2018-07-26 | Genomedx Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| AU2018230784A1 (en) | 2017-03-09 | 2019-10-10 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| WO2018205035A1 (en) | 2017-05-12 | 2018-11-15 | Genomedx Biosciences, Inc | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
| CN113025721A (zh) * | 2021-04-28 | 2021-06-25 | 苏州宏元生物科技有限公司 | 一种前列腺癌诊断和预后评估试剂盒 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995006750A1 (en) * | 1993-09-03 | 1995-03-09 | Cellpro, Incorporated | Methods for quantifying the number of cells containing a selected nucleic acid sequence in a heterogenous population of cells |
| JP2000500329A (ja) * | 1995-10-23 | 2000-01-18 | インペリアル キャンサー リサーチ テクノロジィ リミテッド | 癌罹病性の診断およびその治療 |
| US6479263B1 (en) * | 1996-11-14 | 2002-11-12 | Baylor College Of Medicine | Method for detection of micrometastatic prostate cancer |
| US6140049A (en) * | 1996-11-21 | 2000-10-31 | Genset | Detection and early diagnosis of prostate cancer |
| JPH10276780A (ja) * | 1997-04-01 | 1998-10-20 | Sumitomo Metal Ind Ltd | PSA mRNAの検出方法及び検出キット |
| US6200765B1 (en) * | 1998-05-04 | 2001-03-13 | Pacific Northwest Cancer Foundation | Non-invasive methods to detect prostate cancer |
-
2000
- 2000-06-27 FR FR0008266A patent/FR2810677B1/fr not_active Expired - Fee Related
-
2001
- 2001-05-22 DE DE60108245T patent/DE60108245D1/de not_active Expired - Lifetime
- 2001-05-22 EP EP01938296A patent/EP1294941B1/de not_active Expired - Lifetime
- 2001-05-22 AU AU2001263992A patent/AU2001263992A1/en not_active Abandoned
- 2001-05-22 AT AT01938296T patent/ATE286541T1/de not_active IP Right Cessation
- 2001-05-22 WO PCT/FR2001/001566 patent/WO2002000929A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| FR2810677B1 (fr) | 2004-10-01 |
| DE60108245D1 (de) | 2005-02-10 |
| EP1294941A1 (de) | 2003-03-26 |
| WO2002000929A1 (fr) | 2002-01-03 |
| FR2810677A1 (fr) | 2001-12-28 |
| AU2001263992A1 (en) | 2002-01-08 |
| EP1294941B1 (de) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60108245D1 (de) | Diagnostisches in vitro-verfahren für prostatakrebs sowie hierfür geeignetes testsystem | |
| EP1035215A3 (de) | Verfahren und Sondenset zur Erkennung von Krebs | |
| IL149171A0 (en) | Elisa for vegf | |
| CA2425761A1 (en) | Non-invasive enzyme screen for tissue remodelling-associated conditions | |
| Breul et al. | Prostate-specific antigen in urine | |
| BR0010068A (pt) | Sistema de identificação do marcador fenotìpico e biológico | |
| WO2004031414A3 (en) | Method for diagnosing prostate cancer | |
| EP1362124A4 (de) | Verfahren und sonden für den nachweis von krebs | |
| WO2003069307A3 (en) | Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer | |
| ATE341349T1 (de) | Sonde für die mikrodialyse | |
| WO2006060265A3 (en) | Methods and systems for prognosis and treatment of solid tumors | |
| WO2001092877A3 (en) | Method of identifying and/or isolating stem cells | |
| FR2795823B1 (fr) | Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial | |
| WO2001007644A3 (en) | Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease | |
| EP1107006A4 (de) | Verfahren zur diagnose von knochenmetastasen und malignen tumoren | |
| FR2810114B1 (fr) | Methode, procede, test immunologique et kit de diagnostic d'un adenocarcinome de la prostate ou d'une hypertrophie benigne de la prostate | |
| NO942653L (no) | Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient | |
| Cohen et al. | The cancer and leukemia group B cancer in the elderly committee: addressing a major cancer need | |
| ATE409002T1 (de) | Gerät für prostatekrebsdiagnose | |
| WO2002072752A3 (en) | Forms of prostate specific antigens and methods for their detection | |
| Joniau et al. | 259 The effect of chemoprevention on PSA and clinical management in patients with high grade prostatic intraepithelial neoplasia | |
| AU2002348101A1 (en) | Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer | |
| EP1724579A3 (de) | Verfahren zur Diagnose von Prostatakrebs und zur Analyse von Prostatatumoren | |
| Mladenov et al. | The diagnosis, biopsy and treatment follow-up by ultrasound in patients with prostatic carcinoma | |
| Roscigno et al. | 260 Isolated mono-and pluri-focal high grade prostatic intraepithelial neoplasia (HGPIN) on initial extended prostate needle biopsies: factors predicting cancer detection on extended re-biopsy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |